⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

Influenza, Seasonal (Fluvirin)×Pyrexia

Pyrexia Reports for Influenza, Seasonal (Fluvirin)

#1 most reported symptom for this vaccine

14,616
Reports
149
Deaths
1,540
Hospitalizations
1.02
Mortality Rate
%
10.5
Hosp. Rate
%

Pyrexia and Influenza, Seasonal (Fluvirin)

Pyrexia has been reported 14,616 times in association with Influenza, Seasonal (Fluvirin) vaccination in VAERS. This represents 12.2% of all 119,695 reports for this vaccine.

Among these reports, 149 mentioned death (1.02%) and 1,540 involved hospitalization (10.5%).

Pyrexia is the #1 most frequently reported symptom for Influenza, Seasonal (Fluvirin) out of 3021 total symptoms.

Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.

What This Means

Seeing 14,616 reports of Pyrexia after Influenza, Seasonal (Fluvirin) vaccination may seem alarming, but context is critical. With 119,695 total reports for this vaccine (representing many millions of doses), Pyrexia appears in only 12.2% of reports.

The mortality rate of 1.02% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.

Important Context

Association, not causation: These reports show Pyrexia occurred after vaccination, not that the vaccine caused it.
Background rates: Pyrexia may occur naturally at baseline rates in the population, unrelated to vaccination.
Anyone can report: VAERS accepts reports from anyone — patients, parents, healthcare providers — without requiring medical verification.
Denominator missing: VAERS counts reports, not rates per dose. Without knowing how many doses were given, raw counts can be misleading. Learn more →

Quick Facts

Reports:14,616
Deaths:149
Hospitalizations:1,540
% of Vaccine:12.2%
Rank:#1 of 3021

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.